Meetodi tõendite kirje

Double-blind adaptive experiment

A double-blind adaptive experiment combines two powerful design features: double-blinding, which conceals treatment assignment from both participants and outcome assessors to prevent bias, and adaptive modification, which allows pre-specified changes to the trial's course — such as sample size re-estimation, allocation ratio shifts, or arm dropping — based on accumulating interim data. The result is a rigorous, bias-protected design that can respond to emerging evidence without compromising inferential validity.

Sources recorded, not reviewed

Allikakirje

Tsiteeringud kopeeritud meetodi allikakirjest sõna-sõnalt. Nendest ei saa järeldada väidete tasemel kinnitust.

Double-Blind Adaptive Experimental Design

Taksonoomiline meetodikirje · process-pipeline / experimental-design

U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL
Berry, S. M., Carlin, B. P., Lee, J. J., & Muller, P. (2010). Bayesian Adaptive Methods for Clinical Trials. CRC Press. · ISBN 9781439825488

Ava täielik meetod

Kureeritud väited

Väited on salvestatud tõendite registrisse, igal oma hinnanguga.

Kureeritud väiteid veel pole

See vaade ei loo väite hinnangut, kui registris seda pole.

Seotud meetodid

Genereeritud meetodigraafist ja kuvatud masina soovitatud seostena – väiteid ei järeldata.

Taxonomic bucketAdaptive Experimentmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Controlled Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketMulti-arm experimentmachine-suggested · Relational suggestion, not evidence.Used in the same domainRandomized Controlled Trialmachine-suggested · Relational suggestion, not evidence.